N-[3-[(3R,4R)-1-(2,6-dimethylbenzoyl)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-methoxybenzenesulfonamide
C27H30N2O6S — CID 142424388
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[3-[(3R,4R)-1-(2,6-dimethylbenzoyl)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-methoxybenzenesulfonamide
N-[3-[(3R,4R)-1-(2,6-dimethylbenzoyl)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-methoxybenzenesulfonamide (PubChem CID 142424388) has the molecular formula C27H30N2O6S and a molecular weight of 510.61 g/mol. Its IUPAC name is N-[3-[(3R,4R)-1-(2,6-dimethylbenzoyl)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-methoxybenzenesulfonamide.
Molecular Properties
| Compound Name | N-[3-[(3R,4R)-1-(2,6-dimethylbenzoyl)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-methoxybenzenesulfonamide |
|---|---|
| PubChem CID | 142424388 |
| Molecular Formula | C27H30N2O6S |
| Molecular Weight | 510.61 g/mol |
| Exact Mass | 510.18 |
| IUPAC Name | N-[3-[(3R,4R)-1-(2,6-dimethylbenzoyl)-4-methoxypyrrolidin-3-yl]oxyphenyl]-2-methoxybenzenesulfonamide |
| SMILES | COc1ccccc1S(=O)(=O)Nc1cccc(O[C@@H]2CN(C(=O)c3c(C)cccc3C)C[C@H]2OC)c1 |
| InChI | InChI=1S/C27H30N2O6S/c1-18-9-7-10-19(2)26(18)27(30)29-16-23(34-4)24(17-29)35-21-12-8-11-20(15-21)28-36(31,32)25-14-6-5-13-22(25)33-3/h5-15,23-24,28H,16-17H2,1-4H3/t23-,24-/m1/s1 |
| InChIKey | MTNBXXOYMVCEAJ-DNQXCXABSA-N |
| XLogP | 4.03 |
| TPSA | 94.17 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 510.61 |
| LogP ≤ 5 | 4.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142424388 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.